|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Other receivables | ||||||||||||||||
| Spare parts | ||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||
| Exploration and evaluation assets | ||||||||||||||||
| Property, plant and equipment | ||||||||||||||||
| TOTAL NON-CURRENT ASSETS | ||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||
| Trade payables and accrued liabilities | ||||||||||||||||
| Lease liabilities | ||||||||||||||||
| Provision for severance – current | ||||||||||||||||
| Vehicle financing – current | ||||||||||||||||
| Mortgage payable – current | ||||||||||||||||
| DSU liability – current | ||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||
| NON-CURRENT LIABILITIES | ||||||||||||||||
| Vehicle financing | ||||||||||||||||
| Non-current portion | ||||||||||||||||
| Provision for leave and severance | ||||||||||||||||
| Vehicle financing – non-current | ||||||||||||||||
| Mortgage payable – non-current | ||||||||||||||||
| Term Loan | ||||||||||||||||
| NSR option liability | ||||||||||||||||
| DSU liability – non-current | ||||||||||||||||
| TOTAL NON-CURRENT LIABILITIES | ||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||
| Common Shares (no par value, unlimited Common Shares authorized) (issued and outstanding: June 30, 2026 – 35,648,164; December 31, 2025 – 35,502,754) | ||||||||||||||||
| Preferred shares (no par value, 20,000,000 authorized) Series 1 Convertible Preferred Shares (no par value, 4,000,000 authorized) (issued and outstanding: June 30, 2026 – 118,186; December 31, 2025 – 118,186) | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Deficit | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||
Loading...